 |
|
|
| |
Imaging and Biomarker Thresholds to Accurately
Diagnose NASH Cirrhosis in a 180-patient Biopsy-confirmed Cohort
|
| |
| |
EASL 2023 June 21-24 Vienna
Rohit Loomba,1 Mazen Noureddin,2 Rebecca Taub,3 Naim Alkhouri,4 Kris V. Kowdley,5 Greg Everson,6 Stephen A. Harrison7
1University of California San Diego, La Jolla, CA, USA; 2Houston Research Institute, Houston, TX, USA; 3Madrigal Pharmaceuticals, Conshohocken, PA, USA; 4Arizona Liver Health, Tucson, AZ, USA; 5Liver Institute Northwest, Seattle, WA, USA; 6HepQuant, Denver, CO, USA; 7University of Oxford, United Kingdom and Pinnacle Clinical Research, San Antonio, TX.
|
| |
|
|
|
|
|
